DAP Patients Joining ANCHOR Study for Anal Health
(Palm Springs, CA) October 21, 2020 -- There are only four places on the entire West Coast where people living with HIV / AIDS (PLWHA) can participate in The ANCHOR Study, and DAP Health Center is one of them. HPV-related anal cancer disproportionately harms PLWHA, especially cisgender gay men and transgender women. Unfortunately, prevention, treatment and support are difficult for them to find. Now, DAP patients can receive long term screenings and treatment, thanks to our designation as an ANCHOR Study site.
DAP medical and research clinicians worked hard to earn a place in this groundbreaking project. ANCHOR Study seeks to stop cases of preventable anal cancer in PLWHA by establishing testing and treatment protocols.
There are 40 participants enrolled at DAP so far, and “the team is welcoming more,” according to Dr. David Morris, chief medical officer. Participants are paid $100 per study visit to compensate for time, effort, and travel expenses.
For many DAP patients living with HIV, screening and treatment for a variety of cancers is part of their continuum of HIV care. If they take part in ANCHOR Study, they will monitor and support their anal health with top doctors and researchers, staying in contact for five-to-eight years. They will be contributing to groundbreaking scientific research that will help save lives in the future.
Living with HIV puts many of our patients at higher risk for anal cancer, even if they are on successful antiretroviral therapy (ART). ANCHOR Study aims to show treatment of pre-cancerous cells will lead to a reduction of 75% of incident HPV-related anal cancer.
Anyone interested in the ANCHOR Study is invited to contact Greg Jackson, DAP research coordinator, at (760) 992-0445 or email@example.com. To read more about ANCHOR Study at DAP click here.
More about ANCHOR Study
"No one knew that cervical cancer was preventable before the use of Pap smears became widespread in the 1960s and cut the incidence of the disease by 80 percent."- Dr. Joel Palefsky, Principal Investigator
While deaths from AIDS are way down, anal cancer among people living with HIV is on the rise. We think that anal cancer can be prevented by routine screening and removal of precancerous cells. This strategy has reduced cervical cancer rates by 80%. But to get the insurance companies to cover routine anal cancer screening and preventative treatment, we need to prove that this strategy actually prevents cancer. The best way to show that is to recruit people with High Grade Squamous Intraepithelial Lesions (or HSIL for short) into a study and assign them randomly to a treatment arm or a monitoring arm. We then follow everyone for five years to compare the rates of cancer in both study arms. At the end of the study we’ll know whether screening and treatment of HSIL are effective strategies in preventing anal cancer. We’ll also learn a lot about HPV and other risk factors and why these sometimes cause cancer.
About Desert AIDS Project
Desert AIDS Project (DAP) is a humanitarian healthcare organization in Palm Springs, CA offering DAP Total Care – a combination of medical, dental, counseling, social services, support groups, alternative therapies, in-house pharmacy and lab, and other health and wellness services. DAP’s sexual health clinic, The DOCK, offers STI testing and treatment, Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP), and HIV and HCV testing. DAP’s Get Tested Coachella Valley campaign, the nation’s first region-wide free HIV testing and access to care initiative, was recognized by the White House for helping to bring about an AIDS-free future. DAP has earned a “Four Star” rating from Charity Navigator for the twelfth consecutive year – landing DAP in the top 6% of nonprofits rated. The distinction recognizes that we exceed industry standards in terms of our financial health, accountability, and transparency.
Visit www.desertaidsproject.org to learn more.